WO1997013526A1 - Method of improving lipid digestion - Google Patents
Method of improving lipid digestion Download PDFInfo
- Publication number
- WO1997013526A1 WO1997013526A1 PCT/DK1996/000424 DK9600424W WO9713526A1 WO 1997013526 A1 WO1997013526 A1 WO 1997013526A1 DK 9600424 W DK9600424 W DK 9600424W WO 9713526 A1 WO9713526 A1 WO 9713526A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- galactosidase
- strain
- feed
- aspergillus
- mono
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 28
- 230000020958 lipid digestion Effects 0.000 title claims abstract description 9
- 102000005840 alpha-Galactosidase Human genes 0.000 claims abstract description 51
- 108010030291 alpha-Galactosidase Proteins 0.000 claims abstract description 51
- 241001465754 Metazoa Species 0.000 claims abstract description 33
- 230000029087 digestion Effects 0.000 claims abstract description 10
- 150000002632 lipids Chemical class 0.000 claims abstract description 9
- 239000000654 additive Substances 0.000 claims description 19
- 230000000996 additive effect Effects 0.000 claims description 18
- 230000002708 enhancing effect Effects 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 5
- 241000228245 Aspergillus niger Species 0.000 claims description 4
- 241000287828 Gallus gallus Species 0.000 claims description 4
- 241000228215 Aspergillus aculeatus Species 0.000 claims description 3
- 241000228195 Aspergillus ficuum Species 0.000 claims description 3
- 240000006439 Aspergillus oryzae Species 0.000 claims description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 3
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 3
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 3
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 3
- 230000002538 fungal effect Effects 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 3
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 3
- 241000228212 Aspergillus Species 0.000 claims description 2
- 240000002791 Brassica napus Species 0.000 claims description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 2
- 229920000742 Cotton Polymers 0.000 claims description 2
- 241000219745 Lupinus Species 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 240000004713 Pisum sativum Species 0.000 claims description 2
- 235000010582 Pisum sativum Nutrition 0.000 claims description 2
- FLUADVWHMHPUCG-OVEXVZGPSA-N Verbascose Natural products O(C[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](OC[C@@H]2[C@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]3(CO)[C@H](O)[C@@H](O)[C@@H](CO)O3)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 FLUADVWHMHPUCG-OVEXVZGPSA-N 0.000 claims description 2
- 244000309466 calf Species 0.000 claims description 2
- FLUADVWHMHPUCG-SWPIJASHSA-N verbascose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)O3)O)O2)O)O1 FLUADVWHMHPUCG-SWPIJASHSA-N 0.000 claims description 2
- 238000010410 dusting Methods 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 10
- 229920001542 oligosaccharide Polymers 0.000 description 5
- 150000002482 oligosaccharides Chemical class 0.000 description 5
- 241000271566 Aves Species 0.000 description 4
- 235000019621 digestibility Nutrition 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 235000019764 Soybean Meal Nutrition 0.000 description 3
- 235000014590 basal diet Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000004455 soybean meal Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 150000004676 glycans Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- IFBHRQDFSNCLOZ-IIRVCBMXSA-N 4-nitrophenyl-α-d-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-IIRVCBMXSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 241000288147 Meleagris gallopavo Species 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01022—Alpha-galactosidase (3.2.1.22)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
Definitions
- the present invention relates to a method of improving the lipid digestion of animal feed. More specifically, the invention provides a method of improving the digestion of lipids present in the feed supplied to mono-gastric animals, which method comprises administration of an effective amount of an ⁇ - galactosidase.
- Microbial enzymes are well accepted as a class of feed enhancers, that by improving feed digestibility are able to increase the efficiency of the feed utilization.
- Feed enzymes function by enhancing the digestibility of feed components. This enhancement may partly be brought about by degradation of poly- and oligosaccharides in cereals and vegetable proteins. Certain non-starch polysaccharides are responsible for an increased viscosity of the gut contents, but also for masking of readily digestible starches and proteins rendering them less accessible to endogenous digestive enzymes.
- Oligosaccharides are not degraded in the small intestine by the digestive enzymes of mono-gastric animals, and hence do not offer their full energy potential to the animal.
- the fermentation of these oligosaccharides has been associated with scouring in young pigs, and a condition known as black diarrhoea and sticky droppings in turkey poults.
- black diarrhoea and sticky droppings in turkey poults have been associated with scouring in young pigs, and a condition known as black diarrhoea and sticky droppings in turkey poults.
- the hydrolysis of these oligosaccharides are known to solve two problems, one of animal welfare and the other relating to an improved economy in production.
- ⁇ -galactosidase is known to improve the metabolizable energy by converting raffinose and stachyose in e.g. soy and other vegetable proteins into assimilable sugars.
- raffinose and stachyose in e.g. soy and other vegetable proteins into assimilable sugars.
- any effect of ⁇ -galactosidase on the lipid digestion has never been reported.
- the invention relates to the use of an ⁇ - galactosidase for improving the digestion of lipids present in the feed supplied to a mono-gastric animal, characterized by administration of an effective amount of an ⁇ -galactosidase to the mono-gastric animal. Therefore, in a first aspect, the invention provides a method of improving the digestion of lipids present in the feed supplied to mono-gastric animals, which method comprises administration of an effective amount of an ⁇ -galactosidase.
- the invention provides, a feed enhancing additive comprising an ⁇ -galactosidase in an amount effective for improving the lipid digestion.
- the present invention relates to the use of an ⁇ - galactosidase for improving the digestion of lipids among mono- gastric animals. More specifically the invention provides a method of improving the digestion of lipids present in the feed supplied to mono-gastric animals, which method comprises administration of an effective amount of an ⁇ -galactosidase.
- the mono-gastric animal is a poultry, in particular a broiler chick, a layer or a turkey, a pig, in particular a piglet, or a young calf .
- the animal feed composition comprises substantial amounts of leguminous, in particular soybean, cotton seed, lupine, peas and beans, and crucifera, in particular rapeseed.
- the ⁇ -galactosidase administered to the mono-gastric animal preferably is an ⁇ -galactosidase with activity towards the substrates raffinose, stachyose and/or verbascose.
- the ⁇ -galactosidase may be administered in any convenient form, and may be administered either prior to feeding the animal, or simultaneously with feeding the animal.
- the ⁇ -galactosidase is administered simultaneously with feeding the animal, e.g. provided in the form of a feed enhancing additive.
- an effective amount of an ⁇ -galactosidase is the amount of ⁇ -galactosidase necessary for achieving a significantly improved lipid digestion. It is at present contemplated that the amount of ⁇ -galactosidase administered should be in the range of from about 10 to about 20.000 GALU per kg of animal feed, preferably in the range of from about 100 to about 2.000 GALU per kg of animal feed.
- the ⁇ -galactosidase administered to the mono-gastric animal may be of microbial origin, preferably of bacterial or fungal origin.
- Bacterial ⁇ -galactosidases are available from strains of E. coli , and from strains of Bacillus, in particular a strain of Bacillus stearothermophilus or a strain of Bacillus subtilis .
- Fungal ⁇ -galactosidases are available from strains of
- the ⁇ -galactosidases is derived from a strain of Aspergillus oryzae, or a strain of Aspergillus ficuum, a strain of Aspergillus aculeatus, or a strain of Aspergillu ⁇ niger.
- ⁇ -galactosidases also are available from yeast, in particular from a strain of Saccharomyces cereviciae, or from a strain of Saccharomyces oleaginosus .
- the ⁇ -galactosidase is provided in the form of a mono-component preparation, produced by recombinant DNA technology.
- a mono-component preparation produced by recombinant DNA technology.
- the present invention provides a feed enhancing additive, which additive comprises an ⁇ -galactosidase in an amount effective of improving the digestion of lipids.
- a feed enhancing additive is an enzyme preparation comprising one or more feed enhancing enzymes and suitable carriers and/or excipients, and which enzyme preparation is provided in a form that is suitable for being added to animal feed.
- the feed enhancing additive of the invention may be prepared in accordance with methods known in the art and may be in the form of a dry or a licruid preparation.
- the enzyme to be included in the preparation may optionally be stabilized in accordance with methods known in the art.
- the feed enhancing additive of the invention is a granulated enzyme product which may readily be mixed with feed components, or more preferably, form a component of a pre-mix.
- the granulated enzyme product may be coated or un ⁇ coated.
- the particle size of the enzyme granulates preferably is compatible with that of feed and pre-mix components. This provides a safe and convenient mean of incorporating enzymes into feeds.
- the feed enhancing additive of the invention is a stabilized licruid composition, which may be an aqueous or oil-based slurry.
- the liquid composition may optionally be added to the animal feed after pelleting.
- the feed enhancing additive comprises an ⁇ -galactosidase in an amount corresponding to an activity in the range of from about 50 to about 20.000 GALU/g additive, preferably of from about 200 to about 5.000 GALU/g additive.
- the ⁇ -galactosidase activity may be determined relative to a p-nitrophenyl- ⁇ -D-galactopyranoside substrate (p-NPGal) .
- p-NPGal p-nitrophenyl- ⁇ -D-galactopyranoside substrate
- ⁇ - galactosidase hydrolyses the colorless substrate forming p- nitrophenol, which is yellow in alkaline solution, and which color can be monitored spectrophotometrically at 405 nm.
- 1 GALU is defined as the amount of ⁇ -galactosidase required for hydrolyzing 1 ⁇ mol p-
- NPGal per minute under standard conditions (i.e. using 0.80 mM substrate, after incubation for 15 minutes at pH 5.5 and at 37°C) .
- the foodstuff under study was soy bean meal, and the inclusion level at the expense of all basal ingredients was 25%.
- Two experiments of enzyme supplementation were carried out using a commercially available ⁇ -galactosidase preparation (NovozymeTM 696 1000 L, an Aspergillus niger ⁇ -galactosidase preparation available from Novo Nordisk A/S, Denmark) , and an experimental preparation of an ⁇ -galactosidase obtained from a strain of Aspergillus niger according to the method described in WO 94/23022 (cf. in particular Example 4), in Table 2 designated (c) . Both preparations were dosed in amounts equal to an activity of 2,000 GALU/kg soy bean meal.
- the feed composition of the basal diet is shown Table 1, below.
- the balance trial (21-25 days) was carried out according to the European reference method for the in vivo determination of etabolizable energy, MEn [Bourdillon et al . , Br. Poult. Sci. 1990 31 557-565] .
- the broilers were fed the mash diets at a level of 90% of ad libi tum, and the respective excreta were quantitatively collected on a daily basis.
- the excreta were mixed to homogeneity, freeze-dried, equilibrated and finally ground before analysis. Samples of freeze-dried excreta were analyzed for gross energy and fat.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Birds (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Fodder In General (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU72103/96A AU7210396A (en) | 1995-10-10 | 1996-10-08 | Method of improving lipid digestion |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK1135/95 | 1995-10-10 | ||
DK113595 | 1995-10-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997013526A1 true WO1997013526A1 (en) | 1997-04-17 |
Family
ID=8101414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK1996/000424 WO1997013526A1 (en) | 1995-10-10 | 1996-10-08 | Method of improving lipid digestion |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7210396A (en) |
WO (1) | WO1997013526A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399123B1 (en) * | 2000-05-25 | 2002-06-04 | University Of Missouri Board Of Curators | Oligosaccharide removal from animal feed |
WO2002081674A1 (en) * | 2001-04-05 | 2002-10-17 | Universite Laval | Alpha-galactosidase as food-grade genetic marker |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990014101A1 (en) * | 1989-05-16 | 1990-11-29 | Akpharma Inc. | Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars |
WO1994023022A1 (en) * | 1993-03-31 | 1994-10-13 | Novo Nordisk A/S | AN α-GALACTOSIDASE ENZYME |
-
1996
- 1996-10-08 AU AU72103/96A patent/AU7210396A/en not_active Abandoned
- 1996-10-08 WO PCT/DK1996/000424 patent/WO1997013526A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990014101A1 (en) * | 1989-05-16 | 1990-11-29 | Akpharma Inc. | Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars |
WO1994023022A1 (en) * | 1993-03-31 | 1994-10-13 | Novo Nordisk A/S | AN α-GALACTOSIDASE ENZYME |
Non-Patent Citations (1)
Title |
---|
DIALOG INFORMATION SERVICES, File 155, Medline Dialog Accession No. 00798843, Medline Accession No. 83031843, GAUTAM A.K. et al., "Significance of Glycosidases in Myelin-lipid Metabolism. I. Studies in Diencephalon of Fresh Water Turtle (Lissemys Punctata Granosa)"; & J. HIRNFORSCH (GERMANY, EAST) 1982, 23 (3), * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399123B1 (en) * | 2000-05-25 | 2002-06-04 | University Of Missouri Board Of Curators | Oligosaccharide removal from animal feed |
WO2002081674A1 (en) * | 2001-04-05 | 2002-10-17 | Universite Laval | Alpha-galactosidase as food-grade genetic marker |
Also Published As
Publication number | Publication date |
---|---|
AU7210396A (en) | 1997-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ghazi et al. | Improvement of the nutritive value of soybean meal by protease and a-galactosidase treatment in broiler cockerels and broiler chicks | |
Simbaya et al. | The effects of protease and carbohydrase supplementation on the nutritive value of canola meal for poultry: In vitro and in vivo studies | |
Pettersson et al. | Soybean meal and the potential for upgrading its feeding value by enzyme supplementation | |
Żyła et al. | Simultaneous application of phytase and xylanase to broiler feeds based on wheat: in vitro measurements of phosphorus and pentose release from wheats and wheat‐based feeds | |
Zyla et al. | Comparison of the efficacies of a novel Aspergillus niger mycelium with separate and combined effectiveness of phytase, acid phosphatase, and pectinase in dephosphorylation of wheat-based feeds fed to growing broilers | |
Thorpe et al. | Vegetable protein meals and the effects of enzymes. | |
Ndego et al. | Biochemical characterization of solid state fermented maize cob (Zea mays) using Rhizopus oligosporusand its application in poultry feed production | |
US20020146484A1 (en) | Concentrated spent fermentation beer of saccharopolyspora erythraea activated by an enzyme mixture as a nutitional feed supplement | |
AU714602B2 (en) | Animal feed additives | |
US7211281B2 (en) | Method for improving the activity of enzymes | |
AU2014339904B2 (en) | Use of ferulic acid esterase to improve performance in monogastric animals | |
CS202077B2 (en) | Fodder mixture for agricultural animals | |
WO1997013526A1 (en) | Method of improving lipid digestion | |
Pluske et al. | Releasing energy from rice bran, copra meal and canola in diets using exogenous enzymes. | |
Ajayi | Ileal crude protein digestibility of feather meal supplemented with protease in broiler chickens | |
Egbune et al. | Inclusion of a locally produced animal performance supplement in broilers’ ration | |
Aok | Effect of feed enzymes and energy level on broiler chicken (Gallus domesticus) performance in Kenya | |
IE903685A1 (en) | Feedstuffs | |
EP4297583A1 (en) | Method of improving carbohydrate digestibility by a carbohydratase in an animal feed by employing serine protease | |
WO2022179757A1 (en) | Method of improving carbohydrate digestibility by a carbohydratase in an animal feed by employing serine protease | |
Näsi | Digestibility and protein utilization responses of soybean and rape seed meal to physical and enzymatic treatments in diets for growing pigs | |
Baloch et al. | Partial Replacement of Sunflower Meal with Phytase Enzyme on Nutrient Digestibility of Broiler | |
Sayed et al. | Effect of Palm Kernel Cake and Probiotics on Growth Performance of Growing Barki Lambs | |
NASI | Digestibility and protein utilization responses of soybean and rape seed meal to physical and enzymatic treatments in diets for growing pigs | |
CN116887689A (en) | Method for improving the digestibility of carbohydrates in animal feeds by carbohydrases by using serine proteases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |